Caribou Biosciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
10.26 |
9.44 |
28.50 |
34.44 |
260.38 |
1,790.92 |
| Przychód Δ r/r |
0.00% |
-7.99% |
201.91% |
20.84% |
656.05% |
587.80% |
| Przychód (min) |
8.25 |
8.28 |
16.88 |
20.39 |
154.19 |
1,060.52 |
| Przychód (max) |
11.93 |
11.59 |
38.11 |
46.05 |
348.17 |
2,394.72 |
| EBITDA (średnia) |
-10.26 |
-9.44 |
-28.50 |
-34.44 |
-260.38 |
-1,790.92 |
| EBIT (średnia) |
-10.26 |
-9.44 |
-28.50 |
-34.44 |
-260.38 |
-1,790.92 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-147.86 |
-134.83 |
-142.38 |
-129.78 |
-73.83 |
317.92 |
| Zysk netto % |
-1441.13% |
-1428.31% |
-499.60% |
-376.83% |
-28.36% |
17.75% |
| EPS (średnia) |
-1.66 |
-1.49 |
-1.23 |
-1.45 |
-0.82 |
3.52 |
| Liczba analityków (Przychody) |
7 |
5 |
7 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
5 |
3 |
3 |
5 |
2 |
1 |
| symbol |
CRBU |
CRBU |
CRBU |
CRBU |
CRBU |
CRBU |